Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Dysthymic Disorder
- Microdosing Psychedelics to Improve Mood
- eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
- Pramipexole to Target "Anhedonic Depression"
- L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
- A Study of L-DOPA for Depression and Slowing in Older Adults
- eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients
- Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
- Desvenlafaxine Monotherapy in Dysthymia
- A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
- Duloxetine Treatment in Elderly With Dysthymia
- Desvenlafaxine vs. Placebo Treatment of Chronic Depression
- Oxytocin Add-on for Stable Depressed Patients
- Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms
- Quetiapine in Co-Morbid Depressive and Anxiety Disorders
- Project to Improve Symptoms and Mood in People With Spinal Cord Injury
- Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
- Dichotic Listening as a Predictor of Medication Response in Depression
- Duloxetine for Chronic Depression: a Double-blind Study
- Treatment of Depression Following Multiple Brain Tests
- Dichotic Listening as a Predictor of Medication Response in Depression
- Are Two Antidepressants a Good Initial Treatment for Depression?
- Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial
- A Study of Omega-3 as a Treatment for Major Depression
- Medications for the Treatment of Dysthymic Disorder and Double Depression
- Wellbutrin XL for Dysthymic Disorder
- Escitalopram in the Treatment of Dysthymic Disorder, Double Blind